Warning: ltrim() expects parameter 1 to be string, object given in
/var/www/html/wp-includes/formatting.php on line
4292
Warning: ltrim() expects parameter 1 to be string, object given in
/var/www/html/wp-includes/formatting.php on line
4292
Warning: ltrim() expects parameter 1 to be string, object given in
/var/www/html/wp-includes/formatting.php on line
4292
Warning: ltrim() expects parameter 1 to be string, object given in
/var/www/html/wp-includes/formatting.php on line
4292
Warning: ltrim() expects parameter 1 to be string, object given in
/var/www/html/wp-includes/formatting.php on line
4292
記者李振麟/台北報導
Johnson & Johnson’s 嬌生疫苗/ The Conversation
在南非約480,000名醫護人員參與的大型醫療注射臨床試驗報告顯示,目前公司(JNJ US)的新冠疫苗是能夠預防66%之重症住院與96%死亡。
此次所謂「Sisonke」研究的Glenda Gray在週五記者會上指出,嬌生疫苗對抗Delta株的效力要比Beta株(即南非變異株)好,在長達八個月的持續醫療效力,受試者中只有兩名出現過血小板低下的副作用,其餘檢測正常。